(MedPage Today) — An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive survival outcomes in patients with resected pancreatic and colorectal cancers, according to final results…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116973
Author :
Publish date : 2025-08-13 16:10:00
Copyright for syndicated content belongs to the linked Source.
